Nordicus Partners Corporation just moved. Here's exactly what to do next.
Who to reach, what to say, and why now — on Nordicus Partners Corporation, plus every contract, funding round, and exec hire that follows. Verified, ICP-ranked contacts on demand (email + mobile).
Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.
Contract Type
partnership
Description
Nordicus Partners Corporation has announced that it entered into an agreement with Bio-Convert ApS to acquire 100% of its shares outstanding for 12 million of the Company's restricted common shares in an all-stock transaction to the selling shareholders. Bio-Convert ApS is a Denmark-based clinical-stage biopharmaceutical company focused on revolutionizing the treatment of oral leukoplakia, and Nordicus Partners Corporation aims to support Bio-Convert's mission through this acquisition.